Switch to:
More From Other Websites
ATHERSYS, INC / NEW Files SEC form 8-K, Change in Directors or Principal Officers Jan 13 2017
ETFs with exposure to Athersys, Inc. : December 29, 2016 Dec 29 2016
Ironwood, Allergan Report Positive Linzess IBS-C Study Data Dec 23 2016
Alexion Soliris Fails in Phase II/III Delayed Graft Function Study Dec 22 2016
Bristol-Myers, PsiOxus Ink Deal for Oncolytic Virus Therapy Dec 21 2016
Celgene (CELG) Otezla Approved in Japan for Two Indications Dec 21 2016
How Iradimed Corp (IRMD) Stacks Up Against Its Peers Dec 15 2016
ETFs with exposure to Athersys, Inc. : December 13, 2016 Dec 13 2016
Emergent BioSolutions (EBS) in Focus: Stock Rises 18.9% Dec 12 2016
ETFs with exposure to Athersys, Inc. : November 29, 2016 Nov 29 2016
Epizyme Tazemetostat Gets Fast Track Designation in U.S. Nov 29 2016
Athersys, Inc. :ATHX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 Nov 28 2016
Navidea Inks Deal to to Sell Lymphoseek to Cardinal Health Nov 25 2016
ATHERSYS, INC / NEW Financials Nov 17 2016
New Strong Buy Stocks for November 14th Nov 14 2016
Athersys 3Q Loss $6M or 7 Cents a Share (ATHX) Nov 10 2016
Edited Transcript of ATHX earnings conference call or presentation 9-Nov-16 9:30pm GMT Nov 09 2016
Athersys Reports Third Quarter 2016 Results Nov 09 2016
ATHERSYS, INC / NEW Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 09 2016
Athersys Reports Third Quarter 2016 Results Nov 09 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK